A new research has found that an HIV enzyme plays a crucial role in
driving Alzheimer’s- related brain pathology by altering the APP gene.
The findings warrant “immediate clinical evaluation of HIV antiretroviral therapies in people with Alzheimer’s disease,” according to the authors of the study.
The new study published in the journal ‘Nature’, offers unprecedented revelations into the APP gene, which provides instructions for making a protein called amyloid precursor protein.
This protein is found in many tissues and organs, including the brain. Mutations in this gene have been implicated in Alzheimer’s.
Alzheimer’s is a type of dementia that causes problems with memory, thinking and behaviour. Dementia is not a specific disease.
It’s an overall term that describes a group of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person’s ability to perform everyday activities. Alzheimer’s disease accounts for 60 to 80 percent of cases.
The findings warrant “immediate clinical evaluation of HIV antiretroviral therapies in people with Alzheimer’s disease,” according to the authors of the study.
The new study published in the journal ‘Nature’, offers unprecedented revelations into the APP gene, which provides instructions for making a protein called amyloid precursor protein.
This protein is found in many tissues and organs, including the brain. Mutations in this gene have been implicated in Alzheimer’s.
Alzheimer’s is a type of dementia that causes problems with memory, thinking and behaviour. Dementia is not a specific disease.
It’s an overall term that describes a group of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person’s ability to perform everyday activities. Alzheimer’s disease accounts for 60 to 80 percent of cases.